Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000003

Chairperson & CEO sold 9,500 shares at an average $499.42 ($4,744,467)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

17 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-03 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $146.03 $1,387,285 9,630 D
2026-03-03 Sale : show line 2 in the form 10b5-1 −283 $491.68 $139,146 9,347 D
2026-03-03 Sale : show line 3 in the form 10b5-1 −340 $492.53 $167,462 9,007 D
2026-03-03 Sale : show line 4 in the form 10b5-1 −456 $493.71 $225,132 8,551 D
2026-03-03 Sale : show line 5 in the form 10b5-1 −680 $494.75 $336,431 7,871 D
2026-03-03 Sale : show line 6 in the form 10b5-1 −555 $495.87 $275,209 7,316 D
2026-03-03 Sale : show line 7 in the form 10b5-1 −407 $496.71 $202,161 6,909 D
2026-03-03 Sale : show line 8 in the form 10b5-1 −1,075 $498.01 $535,362 5,834 D
Open-market sales · 9,500 sh · avg $499.42 · $4,744,467

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-03 Exercise or conversion : show line 18 in the form 10b5-1 Stock Option −9,500 221,000 D
Loading xslF345X05/primarydocument.xml…